CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case
April 20, 2018 at 13:02 PM EDT
BOSTON, April 20 (Reuters) - Dicerna Pharmaceuticals Inc on Friday said it will pay $15 million plus stock to Alnylam Pharmaceuticals Inc to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.